Quiz: The BFAST Study for Non-Small Cell Lung Cancer
In our lung cancer quiz, you’ll get to test your knowledge on the BFAST study.
What is the significance of the BFAST trial (NCT03178552)?
a. It is a study investigating whether upfront brain radiotherapy is superior to “at progression” brain radiotherapy in patients with non-small cell lung cancer (NSCLC) and asymptomatic brain metastases.
b. It is an ongoing global study evaluating the relationship between blood-based next-generation sequencing (NGS) detection of actionable genetic alterations in circulating tumor DNA and activity of targeted therapies and immunotherapy in patients with first-line advanced NSCLC.
c. It is a study assessing the effect of molecular testing and the introduction of novel therapeutic options on the use of systemic therapy and overall survival for patients with advanced NSCLC.
d. t is a study assessing the efficacy and safety of AB928 plus carboplatin, pemetrexed, and a PD-1 antibody in patients with metastatic NSCLC.
Newsletter
Stay up to date on recent advances in the multidisciplinary approach to cancer.
